Financial Ratios

ZYDUS HEALTHCARE LTD.

NSE : NABSE : 500156ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE473.200 (0 %)
PREV CLOSE ( ) 473.20
OPEN PRICE ( ) 478.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )472.00 490.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)3360.373213.821045.16849.77790.78
   CEPS(Rs)6011.065863.133668.203460.833380.18
   DPS(Rs)780.000.000.0015.001150.00
   Book NAV/Share(Rs)23437.3320862.2117638.7116607.3719855.30
   Tax Rate(%)-2.178.4752.1742.4856.92
Margin Ratios
   Core EBITDA Margin(%)31.0632.9831.0328.4029.45
   EBIT Margin(%)19.4121.9615.0711.2512.80
   Pre Tax Margin(%)19.3921.9414.9011.1812.73
   PAT Margin (%)19.8120.097.136.435.48
   Cash Profit Margin (%)35.4436.6425.0226.2023.44
Performance Ratios
   ROA(%)11.8211.553.863.202.75
   ROE(%)15.1716.696.104.663.88
   ROCE(%)14.8616.2910.146.487.20
   Asset Turnover(x)0.600.580.540.500.50
   Sales/Fixed Asset(x)0.610.570.530.480.53
   Working Capital/Sales(x)6.163.582.424.924.33
Efficiency Ratios
   Fixed Capital/Sales(x)1.651.741.882.071.87
   Receivable days25.8624.9022.8629.5834.31
   Inventory Days47.4452.4348.2847.4843.41
   Payable days222.54240.04220.65235.94223.52
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)0.00-0.110.280.320.33
   EV/Core EBITDA(x)0.00-0.310.841.031.07
   EV/EBIT(x)0.00-0.491.842.832.57
   EV/CE(x)0.00-0.060.140.160.17
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)6.009.1210.99-8.385.30
   Core EBITDA Growth(%)5.2916.7817.95-7.6226.28
   EBIT Growth(%)-6.3259.0248.68-19.4891.81
   PAT Growth(%)4.56207.5022.997.4690.67
   EPS Growth(%)4.56207.5022.997.4690.67
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)1.572.012.431.822.25
   Quick Ratio(x)1.161.461.931.291.70
   Interest Cover(x)1190.501270.8390.47169.74182.05
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.